Table 3.
Results of the MINORS evaluation.
| MINORS item | Algarni 2018 | Churchill 1991 | Fang 202 | Huang 2020 | Steinberg 1990 | Sun 2014 | Tomaru 2021 | Vulpiani 2012 | Wiesmann 1998 | Wu 2018 | Wang 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 2. Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| 3. Prospective collection of data | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 |
| 4. Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 5. Unbiased assessment of the study endpoint | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 6. Follow-up period appropriate to the aim of the study | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 7. Loss to follow up less than 5% | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 8. Prospective calculation of the study size | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 9. An adequate control group | - | - | 2 | - | 2 | 2 | 2 | - | - | - | 2 |
| 10. Contemporary groups | - | - | 2 | - | 0 | 2 | 1 | - | - | - | 2 |
| 11. Baseline equivalence of groups | - | - | 2 | - | 1 | 2 | 2 | - | - | - | 2 |
| 12. Adequate statistical analyses | - | - | 2 | - | 2 | 2 | 2 | - | - | - | 2 |
| Total score | 10 | 10 | 17 | 10 | 14 | 20 | 17 | 10 | 10 | 12 | 18 |